The number of tumor infiltrating CD8+ and CD138+ lymphocytes, and of CD68+ macrophages, and the CD68+/CD8+ ratio did not differ according to clinical, biochemical, pathological, and morphological features of the study population (Table 2). The gene discussed is CD8A; the disease is neoplasm.